{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:13:40Z","timestamp":1773260020227,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Trace Elements in Medicine and Biology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtemb.2025.127680","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T02:43:47Z","timestamp":1749177827000},"page":"127680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring the chemotherapeutic potential of diosmetin ruthenium-p-cymene complex in bladder cancer treatment through the regulation of the PI3K\/\u03b2-catenin\/TJP1\/AR signaling pathway"],"prefix":"10.1016","volume":"90","author":[{"given":"Sidhanta","family":"Sil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakuntala","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishita","family":"Seal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2980-0362","authenticated-orcid":false,"given":"Souvik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtemb.2025.127680_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer Journal Clinicians"},{"key":"10.1016\/j.jtemb.2025.127680_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12935-023-03069-4","article-title":"Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics","volume":"23","author":"Farouk","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.jtemb.2025.127680_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"7","key":"10.1016\/j.jtemb.2025.127680_bib4","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/biomedicines12071610","article-title":"The role of the PI3K\/Akt\/mTOR axis in head and neck squamous cell carcinoma","volume":"12","author":"Jiang","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtemb.2025.127680_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118513","article-title":"PI3K\/AKT\/mTOR signaling in gastric cancer: epigenetics and beyond","volume":"262","author":"Fattahi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jtemb.2025.127680_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jtemb.2025.127680_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-024-01899-w","article-title":"Therapeutic advances of targeting receptor tyrosine kinases in cancer","volume":"9","author":"Tomuleasa","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.jtemb.2025.127680_bib8","article-title":"PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jtemb.2025.127680_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jtemb.2025.127680_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.jtemb.2025.127680_bib11","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jtemb.2025.127680_bib12","first-page":"1339","article-title":"Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells","author":"Maxwell","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.jtemb.2025.127680_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cancers9020020","article-title":"Androgen receptor signaling in bladder cancer","volume":"9","author":"Li","year":"2017","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.jtemb.2025.127680_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/cells12020243","article-title":"Tight junction protein signaling and cancer biology","volume":"12","author":"Nehme","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jtemb.2025.127680_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/\u03b2-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.jtemb.2025.127680_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.jtemb.2025.127680_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5527\/wjn.v8.i5.83","article-title":"WNT\/\u03b2-catenin signaling in urothelial carcinoma of bladder","volume":"8","author":"Garg","year":"2019","journal-title":"World J. Nephrol."},{"issue":"11-12","key":"10.1016\/j.jtemb.2025.127680_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.18632\/genesandcancer.128","article-title":"Active \u03b2-catenin is regulated by the PTEN\/PI3 kinase pathway: a role for protein phosphatase PP2A","volume":"7","author":"Persad","year":"2016","journal-title":"Genes Cancer"},{"issue":"7","key":"10.1016\/j.jtemb.2025.127680_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/genes11070719","article-title":"PTEN alterations and their role in cancer management: are we making headway on precision medicine?","volume":"11","author":"Fusco","year":"2020","journal-title":"Genes"},{"issue":"8","key":"10.1016\/j.jtemb.2025.127680_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/biomedicines8080264","article-title":"PTEN, a barrier for proliferation and metastasis of gastric cancer cells: from molecular pathways to targeting and regulation","volume":"8","author":"Ashrafizadeh","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtemb.2025.127680_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105303","article-title":"A toxicological evaluation for safety assessment of ruthenium-based diosmetin complex in rats","volume":"137","author":"Sil","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jtemb.2025.127680_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s13104-015-1618-6","article-title":"In vitro antioxidant and free radical scavenging activity of different parts of Tabebuia pallida growing in Bangladesh","volume":"8","author":"Rahman","year":"2015","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.jtemb.2025.127680_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \"antioxidant power\": the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jtemb.2025.127680_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jembe.2003.10.008","article-title":"Measuring antioxidant potential in corals using the PRAP assay","volume":"302","author":"Griffin","year":"2004","journal-title":"J. Exp. Mar. Biol. Ecol."},{"issue":"2","key":"10.1016\/j.jtemb.2025.127680_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.envexpbot.2004.04.002","article-title":"Relationship of cold acclimation. Total phenolic content and antioxidant capacity with chilling tolerance in Petunia (Petunia x Hybrid)","volume":"53","author":"Pennycooke","year":"2005","journal-title":"Environ. Exp. Bot."},{"issue":"1","key":"10.1016\/j.jtemb.2025.127680_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpae015","article-title":"An improved method for measuring catalase activity in biological samples","volume":"9","author":"Hadwan","year":"2024","journal-title":"Biol. Methods Protoc."},{"issue":"7","key":"10.1016\/j.jtemb.2025.127680_bib27","first-page":"647","article-title":"Effect of anesthetic ether on lipid peroxidation and superoxide dismulatase isozymes of young and adult rat brain","volume":"27","author":"Awasthi","year":"1989","journal-title":"Indian J. Exp. Biol."},{"issue":"4073","key":"10.1016\/j.jtemb.2025.127680_bib28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1126\/science.179.4073.588","article-title":"Selenium: biochemical role as a component of glutathione peroxidase","volume":"179","author":"Rotruck","year":"1973","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jtemb.2025.127680_bib29","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resistance"},{"issue":"9","key":"10.1016\/j.jtemb.2025.127680_bib30","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtemb.2025.127680_bib31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.jtemb.2025.127680_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112442","article-title":"Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms","volume":"146","author":"Slika","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jtemb.2025.127680_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102145","article-title":"Highlighting function of Wnt signalling in urological cancers: molecular interactions, therapeutic strategies, and (nano)strategies","volume":"50","author":"Hashemi","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jtemb.2025.127680_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154854","article-title":"The pathophysiology of the cell cycle in cancer and treatment strategies using various cell cycle checkpoint inhibitors","volume":"251","author":"Almalki","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.jtemb.2025.127680_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/fsn3.3784","article-title":"Reactive oxygen species in biological systems: pathways, associated diseases, and potential inhibitors\u2014a review","volume":"12","author":"Rauf","year":"2023","journal-title":"Food Sci. Nutr."},{"key":"10.1016\/j.jtemb.2025.127680_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-021-01488-3","article-title":"The crosstalk between reactive oxygen species and noncoding RNAs: from cancer code to drug role","volume":"21","author":"Zuo","year":"2022","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.jtemb.2025.127680_bib37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/cancers11081076","article-title":"PTEN tumor-suppressor: the dam of stemness in cancer","volume":"11","author":"Luongo","year":"2019","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.jtemb.2025.127680_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34950","article-title":"A systematic review of mechanisms of PTEN gene down-regulation mediated by miRNA in prostate cancer","volume":"10","author":"Bergez-Hern\u00e1ndez","year":"2024","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.jtemb.2025.127680_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/IGC.0000000000000626","article-title":"Expression of PTEN and \u03b2-catenin and their relationship with clinicopathological and prognostic factors in endometrioid type endometrial cancer","volume":"26","author":"Sal","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jtemb.2025.127680_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12964-022-00999-w","article-title":"PTEN overexpression and nuclear \u03b2-catenin stabilization promote morular differentiation through induction of epithelial\u2013mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma","volume":"20","author":"Yokoi","year":"2022","journal-title":"Cell Commun. Signal"},{"issue":"59","key":"10.1016\/j.jtemb.2025.127680_bib41","doi-asserted-by":"crossref","first-page":"100614","DOI":"10.18632\/oncotarget.21899","article-title":"Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis","volume":"8","author":"Ko","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jtemb.2025.127680_bib42","article-title":"Assessment of Ki-67 proliferation index in prognosis prediction in patients with nonmetastatic clear cell renal cell carcinoma and tumor thrombus","volume":"42","author":"Zhao","year":"2024","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"10.1016\/j.jtemb.2025.127680_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jtemb.2025.127680_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.jtemb.2025.127680_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10608","article-title":"Cisplatin for cancer therapy and overcoming chemoresistance","volume":"8","author":"Ranasinghe","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jtemb.2025.127680_bib46","article-title":"Metal complexes of flavonoids: their synthesis, characterization and enhanced antioxidant and anticancer activities","volume":"11","author":"Khater","year":"2019","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.jtemb.2025.127680_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/ijms22020646","article-title":"Iron complexes of flavonoids-antioxidant capacity and beyond","volume":"22","author":"Kej\u00edk","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Trace Elements in Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X25000938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X25000938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:56:10Z","timestamp":1762332970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0946672X25000938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0946672X25000938"],"URL":"https:\/\/doi.org\/10.1016\/j.jtemb.2025.127680","relation":{},"ISSN":["0946-672X"],"issn-type":[{"value":"0946-672X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the chemotherapeutic potential of diosmetin ruthenium-p-cymene complex in bladder cancer treatment through the regulation of the PI3K\/\u03b2-catenin\/TJP1\/AR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Trace Elements in Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtemb.2025.127680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127680"}}